Innate Pharma S.A. announced that Tracy Rossin was appointed as a member of Executive Committee on September 12, 2019 as Vice President, Global Head of Communications of the Company. Ms. Rossin brings more than 20 years of strategic communications experience to Innate, including 12 years atAstraZeneca/MedImmune, where she held multiple U.S. and global communications roles, including two European assignments, for key therapeutic areas across AstraZeneca's portfolio. Most recently, she was Head of Corporate Affairs at MedImmune, managing the company's communications functions, including supporting early-stage oncology biologic communications. Frédérique Brune was appointed as a member of Executive Committee on July 1, 2019 as VP Development, CMC and Supply Chain, after previously serving as Senior Director of Development, CMC and Pharmaceutical Operations since March 2017. Prior to joining us, Ms. Brune served as Quality Director of Bioproduction at LFB-Biotechnologies from March 2016 to March 2017. From September 2007 to March 2016, she worked as Director of Development programs as well as Interim Head Pharmacist at LFB-Biotechnologies. Prior to LFB-Biotechnologies, Ms. Brune served in various roles and responsibilities from 2001 to 2007 at Pierre Fabre Research Institute, including as Analytical Development and Quality Control Director, Pharmacist delegate and Program Director.